Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kohrle, J.
Right arrow Articles by Leonard, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kohrle, J.
Right arrow Articles by Leonard, J. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 265, Issue 11, 6155-6163, 04, 1990

Affinity labeling of rat liver and kidney type I 5'-deiodinase. Identification of the 27-kDa substrate binding subunit

J Kohrle, UB Rasmussen, DM Ekenbarger, S Alex, H Rokos, RD Hesch and JL Leonard
Department of Physiology, University of Massachusetts Medical School, Worcester 01655.

Extrathyroidal production of 3,3',5-triiodothyronine from the thyroid secretory product, thyroxine, is catalyzed by tissue-specific iodothyronine 5'-deiodinases. Type I 5'-deiodinase (5'D-I) produces greater than 75% of the T3 found in the circulation and in thyroid hormone-responsive tissues and is most abundant in rat liver and kidney. In this study, we used the bromoacetyl derivatives of T4 (N- bromoacetyl-[125I]L-thyroxine, BrAcT4) and T3 (N-bromoacetyl- [125I]3,3',5-triiodothyronine, BrAcT3) as alkylating affinity labels to identify 5'D-I-related protein(s). BrAcT4 and BrAcT3 rapidly and irreversibly inactivated 5'D-I activity in liver and kidney microsomes. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of affinity labeled 5'D-I preparations showed that approximately 80% of the affinity label was incorporated into a protein with a Mr of 27,000 (p27). 5'D-I substrates and inhibitors specifically blocked affinity labeling of p27 with a rank order of potency (BrAcT4 greater than BrAcT3 greater than 3,5,3'-triiodothyronine (rT3) approximately flavone EMD 21388 greater than iodoacetate greater than N-acetyl-T4 (NAcT4) greater than N-acetyl-T3 (NAcT3] identical to that determined for inhibition of 5'-deiodination. Hyper- and hypothyroidism-induced increases and decreases in 5'D-I activity, respectively, were matched by comparable changes in the quantity of affinity labeled p27. BrAcT3 was a less effective affinity label for p27 and minor labeling of a new band with 53 kDa was observed. Molecular sieve chromatography of detergent-solubilized 5'D-I showed coincident peaks of p27 and 5'- deiodinating activity with an apparent Mr approximately 51,000. Two- dimensional gel electrophoresis showed that p27 was a single polypeptide with a pI of 6.1. Approximately 2-5 pmol of p27 were present per mg of liver microsomal protein, equal to previous estimates for 5'D-I content. Our results suggest that p27 represents the substrate binding subunit of type I 5'-deiodinase, the enzyme catalyzing the key reaction in the activation of T4 to the thyromimetically active T3.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Endocr. Rev.Home page
J. Kohrle, F. Jakob, B. Contempre, and J. E. Dumont
Selenium, the Thyroid, and the Endocrine System
Endocr. Rev., December 1, 2005; 26(7): 944 - 984.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
G. G J M Kuiper, W. Klootwijk, and T. J Visser
Expression of recombinant membrane-bound type I iodothyronine deiodinase in yeast
J. Mol. Endocrinol., June 1, 2005; 34(3): 865 - 878.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. L. Leonard, G. Simpson, and D. M. Leonard
Characterization of the Protein Dimerization Domain Responsible for Assembly of Functional Selenodeiodinases
J. Biol. Chem., March 25, 2005; 280(12): 11093 - 11100.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. A. Shepherdley, W. Klootwijk, K. W. Makabe, T. J. Visser, and G. G. J. M. Kuiper
An Ascidian Homolog of Vertebrate Iodothyronine Deiodinases
Endocrinology, March 1, 2004; 145(3): 1255 - 1268.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. G. J. M. Kuiper, F. Wassen, W. Klootwijk, H. van Toor, E. Kaptein, and T. J. Visser
Molecular Basis for the Substrate Selectivity of Cat Type I Iodothyronine Deiodinase
Endocrinology, December 1, 2003; 144(12): 5411 - 5421.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. G. J. M. Kuiper, W. Klootwijk, and T. J. Visser
Substitution of Cysteine for Selenocysteine in the Catalytic Center of Type III Iodothyronine Deiodinase Reduces Catalytic Efficiency and Alters Substrate Preference
Endocrinology, June 1, 2003; 144(6): 2505 - 2513.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. G. J. M. Kuiper, W. Klootwijk, and T. J. Visser
Substitution of Cysteine for a Conserved Alanine Residue in the Catalytic Center of Type II Iodothyronine Deiodinase Alters Interaction with Reducing Cofactor
Endocrinology, April 1, 2002; 143(4): 1190 - 1198.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. C. Bianco, D. Salvatore, B. Gereben, M. J. Berry, and P. R. Larsen
Biochemistry, Cellular and Molecular Biology, and Physiological Roles of the Iodothyronine Selenodeiodinases
Endocr. Rev., February 1, 2002; 23(1): 38 - 89.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. L. Leonard, D. M. Leonard, M. Safran, R. Wu, M. L. Zapp, and A. P. Farwell
The Mammalian Homolog of the Frog Type II Selenodeiodinase Does Not Encode a Functional Enzyme in the Rat
Endocrinology, May 1, 1999; 140(5): 2206 - 2215.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
B. C. Sun, J. W. Harney, M. J. Berry, and P. R. Larsen
The Role of the Active Site Cysteine in Catalysis by Type 1 Iodothyronine Deiodinase
Endocrinology, December 1, 1997; 138(12): 5452 - 5458.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Safran, A. P. Farwell, and J. L. Leonard
Catalytic Activity of Type II Iodothyronine 5'-Deiodinase Polypeptide Is Dependent upon a Cyclic AMP Activation Factor
J. Biol. Chem., July 5, 1996; 271(27): 16363 - 16368.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. J. Stachelek, T. F. Kowalik, A. P. Farwell, and J. L. Leonard
Myosin V Plays an Essential Role in the Thyroid Hormone-dependent Endocytosis of Type II Iodothyronine 5'-Deiodinase
J. Biol. Chem., October 6, 2000; 275(41): 31701 - 31707.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. L. Leonard, T. J. Visser, and D. M. Leonard
Characterization of the Subunit Structure of the Catalytically Active Type I Iodothyronine Deiodinase
J. Biol. Chem., January 19, 2001; 276(4): 2600 - 2607.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1990 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement